Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
Ludmilla de Plater(Hôpital Saint-Louis), Elisabetta Marangoni(Université Paris Sciences et Lettres)
Cited by 44
Related Papers
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
|Nature Communications|2023|96
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts
|Molecular Cancer Therapeutics|2012|45